Dr. Elizabeth Leath Perkins, MD

Dr. Perkins practices at Labcorp - Birmingham (1st Ave S) in Birmingham, Alabama.

Dr. Perkins' NPI, 1811105398, was assigned on May 18, 2007. Dr. Perkins graduated from University of Texas Medical School at San Antonio in 2004. Dr. Perkins' Alabama license number on file is 28792.

Dr. Perkins' primary practice is Labcorp - Birmingham (1st Ave S), at 1801 First Ave South, Birmingham, AL 35233. The practice phone is (205) 581-3500.

Dr. Perkins' primary practice is Labcorp - Birmingham (1st Ave S) in Birmingham, Alabama. Dr. Perkins is also affiliated with UAB Hospital. The medical group on file is Rheumatology Care Center. Dmand AI also links Dr. Perkins to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Perkins practices, 7 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Perkins' primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Perkins is board certified in rheumatology by the American Board of Internal Medicine. Dmand AI has Dr. Perkins' licenses on file in 2 states: Alabama and Virginia.

Dmand AI lists arteritis, arthritis, gout, lupus, muscle pain, fibromyalgia, and limb pain, osteoporosis and rheumatoid arthritis among the conditions Dr. Perkins treats.

CMS data shows 217,364 Medicare services from Dr. Perkins across 24 procedure codes in 2024, for 292 Medicare patients. Medicare paid $2,761,460 for them. Every service was in an office.

CMS counts 292 Medicare patients who saw Dr. Perkins in 2024. The largest group is 65 to 74, with 136 patients. 75% of them have arthritis, and 75% have high blood pressure. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Perkins' median patient age at 65, with 85% women.

In 2024, Dr. Perkins wrote 4,867 Medicare Part D claims for 441 patients. 82% of them were for generic drugs. CMS names the drug for 4,554 of them, across 53 drugs with 11 or more claims each, at $5,073,505 in total drug cost. In 2023, CMS named 4,304 claims across 55 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 70 out of 100 for Dr. Perkins for performance year 2024, reported as part of a group. Dr. Perkins accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Perkins, published from 2011 to 2019. 2019 was the busiest year, with 2. Dr. Perkins' most frequent co-authors are Roy Mitchel Fleischmann, MD, Peter Gregersen and Laura B. Hughes, MD.

CMS Open Payments shows 2,702 general payments to Dr. Perkins from 48 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Eli Lilly and Company paid the most, $159,550.

Dmand AI lists 2 awards for Dr. Perkins, most recently CMS Stage 1 EHR in 2013.

Dr. Perkins graduated from University of Texas Medical School at San Antonio in 2004. Dr. Perkins is a member of ACR.

Dr. Perkins is in network with 7 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.